Abstract:Background: Inherited medullary thyroid carcinoma (MTC) is primarily caused by RET mutations that are commonly localized in exons 5, 8, 10, 11, and 13-16. In this study, we report pedigrees for individuals with MTC that harbor a germline S409Y variant within exon 6 of the RET proto-oncogene. Methods: Targeted sequencing was used to diagnose four apparently sporadic MTC index cases carrying the germline RET S409Y (c.1226 C>A) variant. Subsequently, 27 relatives of these individuals underwent clinical and genetic assessments and/or thyroid surgery. Furthermore, in silico analyses and in vitro assays were performed to predict or verify the potential oncogenic activity of the S409Y variant. Results: Overall, 15 of 31 participants were found to carry the RET S409Y variant. Of these, 6 presented with isolated MTC (mean age 50.2 years; range 41-75 years), of which 3 presented with neck lymph node metastases and 2 presented with distant liver or lung metastases. Among the remaining 9 carriers, 3 (mean age 56 years; range 41-76 years) had elevated serum calcium-stimulated calcitonin (sCtn) or concurrent marginally elevated serum calcitonin (Ctn) levels, whereas the other 6 (mean age 37.5 years; range 14-52 years) exhibited typical Ctn/sCtn levels (p < 0.05). None of the 15 carriers in these 4 families presented clinical evidence of pheochromocytoma, hyperparathyroidism, or Hirschsprung's disease. In silico analyses revealed that S409Y was a "possibly damaging" mutation that could affect the RET protein inter-domain interface. An in vitro assay revealed that the phosphorylation level of RET tyrosine 905 was relatively higher in the RET S409Y mutant than in wild-type (WT) RET. Moreover, transfection of HEK 293 cells with S409Y enhanced the phosphorylation activity of AKT, ERK pathways, and it increased cell proliferation compared with WT RET, but to a lesser degree than that for the RET C618Y and C634Y mutations. Conclusions: This study demonstrates that the novel germline RET S409Y variant is likely pathogenic and is associated with lower penetrance of MTC than that for the C618Y and C634Y mutations. Individuals with S409Y should be managed using a personalized approach, and additionally, "at-risk" family members should be evaluated. Additional studies are needed to elucidate the correlation between the S409Y mutation and multiple endocrine neoplasia type 2-specific tumors.

Familial Multinodular Goiter Syndrome with Papillary Thyroid Carcinomas: Mutational Analysis of the Associated Genes in 5 Cases from 1 Chinese Family.

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.

Targeted Dna Sequencing Detects Mutations Related to Susceptibility among Familial Non-Medullary Thyroid Cancer

Genomic characterization of papillary thyroid carcinoma in Chinese Shandong population.

Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

Whole Exome and Target Sequencing Identifies MAP2K5 As Novel Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma

Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.

Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma

Association of Rs944289, Rs965513, and Rs1443434 in TITF1/TITF2 with Risks of Papillary Thyroid Carcinoma and with Nodular Goiter in Northern Chinese Han Populations.

The Rare Intracellular RET Mutation P.s891a in a Chinese Han Family with Familial Medullary Thyroid Carcinoma

Genetic Analysis of a Chinese Han Family with Multiple Endocrine Neoplasia Type 2A.

Genetic landscape of papillary thyroid carcinoma in the Chinese population

Targeted Next-Generation Sequencing in Papillary Thyroid Carcinoma Patients Looking for Germline Variants Predisposing to the Disease.

Identification of a novel CNV at the APC gene in a Chinese family with familial adenomatous polyposis

Are the SNPs of NKX2-1 Associated with Papillary Thyroid Carcinoma in the Han Population of Northern China?

A Multicenter Study Assessing the Prevalence of Germline Genetic Alterations in Chinese Gastric-Cancer Patients

Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma

Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.

[Familial and Genetic Study in a Large Chinese Kindred with Hereditary Nonpolyposis Colorectal Cancer].

Suggestive Evidence of the Genetic Association of TMOD1 and PTCSC2 Polymorphisms with Thyroid Carcinoma in the Chinese Han Population